The EUROPA trial

This publication has 5 references indexed in Scilit:

• Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
  The Lancet, 2003
• European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
  European Heart Journal, 2003
• Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme
  European Heart Journal, 2001
• ANGIOTENSIN‐CONVERTING ENZYME INHIBITORS AND ATHEROSCLEROSIS: RELEVANCE OF ANIMAL MODELS TO HUMAN DISEASE
  Clinical and Experimental Pharmacology and Physiology, 1996
• Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
  New England Journal of Medicine, 1992